Wednesday, July 8, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “healthy” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 1,124
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 1,124 pipeline programs matching "healthy" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

1,124 results for “healthy” Back to intelligence hub

Search results

Page 16 of 47
  1. D9609C00001

    AstraZeneca AB

    Healthy Volunteers

    phase 1 other active

    1 trial
  2. DA-5210 10/500mg

    Dong Wang

    Healthy

    phase 1 small molecule completed

    1 trial
  3. DISC-0974

    Disc Medicine

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial
  4. DISC-3405

    Disc Medicine

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial
  5. DMT in healthy subjects

    Lacuna Pharma Pty Ltd

    Stroke

    phase 1 other active

    1 trial
  6. DNL151

    Denali Therapeutics

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  7. DNL201

    Denali Therapeutics

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  8. DNL343

    Denali Therapeutics

    Healthy Volunteers

    phase 1 small molecule completed

    2 trials
  9. DNL919

    Denali Therapeutics

    Healthy Participant

    phase 1 small molecule completed

    1 trial
  10. DSM265

    United Therapeutics Europe Ltd

    Healthy

    phase 1 small molecule completed

    1 trial
  11. DSP loaded RBC using EryDex System

    Quince Therapeutics

    Healthy

    phase 1 small molecule completed

    1 trial
  12. DV0012

    Lacuna Pharma Pty Ltd

    Healthy Volunteers

    phase 1 other active

    1 trial
  13. Danavorexton

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  14. Danicopan

    Alexion Europe SAS

    Healthy

    phase 1 small molecule completed

    1 trial
  15. Daridorexant

    Jian Li

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial
  16. Dazucorilant

    CORCEPT THERAPEUTICS INC

    Healthy Adults

    phase 1 small molecule completed

    1 trial
  17. Deferitazole (disodium salt, granule)

    Takeda

    Healthy

    phase 1 small molecule terminated

    1 trial
  18. Deflazacort

    PTC THERAPEUTICS, INC.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  19. Deflazacort and rifampin

    PTC THERAPEUTICS, INC.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  20. Denifanstat

    Sagimet Biosciences

    Healthy

    phase 1 small molecule completed

    1 trial
  21. Desmopressin Acetate 0.2 mg Tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    1 trial
  22. Dexamethasone

    NEUROCRINE BIOSCIENCES INC

    Healthy

    phase 1 small molecule completed

    1 trial
  23. Dexlansoprazole

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  24. Dexmethylphenidate Hydrochloride

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.